Skip to content

Estimation of salivary biomarker in various stages of pulpal diseases in oral cavity

Estimation Of Salivary TNF-a Levels In Various Stages Of Pulpal Diseases : A Cross Sectional Study - Not Applicable

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055138
Enrollment
80
Registered
2023-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: Nil: Nil Control Intervention1: GROUP 1 (CONTROL): Group 1 will constitute healthy individuals with no evidence of caries and systemic diseases Control Intervention2: GROUP 2: Group 2 w

Sponsors

Mudit Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria for group 1 1.Patients aged 18-40 years of age 2.Patients with no relevant medical history or absence of any systemic conditions 3.Non-smokers 4.OHI index of 0 and Russel’s Periodontal index (not >0.9) Inclusion criteria for group II,III,IV 1.Patients with mandibular molars diagnosed with symptomatic reversible pulpitis, symptomatic irreversible pulpitis and pulpal necrosis respectively diagnosed according to AAE guidelines 2013 2.Patients with no relevant medical history or absence of any systemic conditions

Exclusion criteria

Exclusion criteria: 1.Use of opioid analgesics or antibiotics 48 hours prior to specimen collection 2.Narcotic drug use - Habit of smoking or tobacco chewing 3.Having conditions that effects saliva flow such as xerostomia, radiotherapy, etc. 4.Having a systemic disease 5.Being pregnant or breastfeeding - 6.Having an infectious disease known to be transmitted by saliva. 7.having Russel’s Periodontal index >0.9 8.Inability to understand the content of the informed consent form

Design outcomes

Primary

MeasureTime frame
To compare salivary TNF-a levels in normal, reversible pulpitis, irreversible pulpitis & necrotic pulpal tissues by using sandwich ELISA techniqueTimepoint: 6-12 months for sample collection & evaluation of samples by ELISA

Secondary

MeasureTime frame
To estimate salivary TNF-a levels in normal pulpal tissues (caries free individuals) Timepoint: 6-12 months for sample collection & evaluation of samples by ELISA;To estimate salivary TNF-a levels in patients diagnosed with pulpal necrosis.Timepoint: 6-12 months for sample collection & evaluation of samples by ELISA;To estimate salivary TNF-a levels in patients diagnosed with reversible pulpitisTimepoint: 6-12 months for sample collection & evaluation of samples by ELISA;To estimate salivary TNF-a levels in patients diagnosed with symptomatic irreversible pulpitisTimepoint: 6-12 months for sample collection & evaluation of samples by ELISA

Countries

India

Contacts

Public ContactMudit Sharma

Manav Rachna Dental College,faridabad

daxabraham.mrdc@mrei.ac.in9910433111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026